These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18604377)

  • 1. [Post-prandial hyperglycemia in type 2 diabetes patients].
    Cruzes AL; Bosco CE; Pandini EV; Hernandez MA; Silva RC
    Arq Bras Endocrinol Metabol; 2008 Jun; 52(4):642-8. PubMed ID: 18604377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.
    Hay LC; Wilmshurst EG; Fulcher G
    Diabetes Technol Ther; 2003; 5(1):19-26. PubMed ID: 12725703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical use of continuous glucose monitoring system in gestational diabetes mellitus and type 2 diabetes complicated with pregnancy].
    Song Y; Yang H
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):579-83. PubMed ID: 25354857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting and post-prandial glycemia and their correlation with glycated hemoglobin in Type 2 diabetes.
    Monami M; Lamanna C; Lambertucci L; Longo R; Cocca C; Addante F; Lotti E; Masotti G; Marchionni N; Mannucci E
    J Endocrinol Invest; 2006; 29(7):619-24. PubMed ID: 16957410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic/glycemic control accuracy, effect and complications of the continuous glucose monitoring system in diabetic patients].
    Maia FF; Araújo LR
    Rev Assoc Med Bras (1992); 2006; 52(6):395-400. PubMed ID: 17242774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of continuous glucose monitoring system (CGMS) to detect postprandial hyperglycemia and unrecognized hypoglycemia in type 1 diabetic patients.
    Maia FF; Araújo LR
    Diabetes Res Clin Pract; 2007 Jan; 75(1):30-4. PubMed ID: 16806560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes.
    Kohnert KD; Augstein P; Heinke P; Zander E; Peterson K; Freyse EJ; Salzsieder E
    Diabetes Res Clin Pract; 2007 Sep; 77(3):420-6. PubMed ID: 17331614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of continuous subcutaneous insulin infusion and multiple daily injections of insulin on glucose variability in older adults with type 2 diabetes.
    Johnson SL; McEwen LN; Newton CA; Martin CL; Raskin P; Halter JB; Herman WH
    J Diabetes Complications; 2011; 25(4):211-5. PubMed ID: 21062674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Accuracy, effect on insulin therapy and glycemic control and complications of the continuous glucose monitoring system in type 1 diabetic patients].
    Maia FF; Araújo LR
    Arq Bras Endocrinol Metabol; 2005 Aug; 49(4):563-8. PubMed ID: 16358086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new insulinotropic agent by using an innovative technology: efficacy and safety of nateglinide determined by continuous glucose monitoring.
    Abrahamian H; Francesconi M; Loiskandl A; Dzien A; Prager R; Weitgasser R
    Diabetes Technol Ther; 2004 Feb; 6(1):31-7. PubMed ID: 15000767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood glucose patterns in type 2 diabetic patients with optimal fasting plasma glucose but high HbA1c.
    Charoenhirunyingyos W; Nitiyanant W; Thabsang P; Sriussadaporn S; Vannasaeng S
    J Med Assoc Thai; 2011 Mar; 94(3):278-85. PubMed ID: 21560834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between 1,5-anhydroglucitol and glycemic excursions in type 2 diabetic patients.
    Sun J; Dou JT; Wang XL; Yang GQ; Lü ZH; Zheng H; Ma FL; Lu JM; Mu YM
    Chin Med J (Engl); 2011 Nov; 124(22):3641-5. PubMed ID: 22340217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The features of postprandial glucose state in type 2 diabetes mellitus].
    Zhou J; Jia WP; Yu M; Ma XJ; Bao YQ; Lu W
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):970-5. PubMed ID: 16759538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of postprandial hyperglycemia after basal insulin therapy: individual and regional differences.
    Shaefer C; Reid T; DiGenio A; Vlajnic A; Zhou R; Ameer B; Riddle M
    Diabetes Metab Res Rev; 2015 Mar; 31(3):269-79. PubMed ID: 25255776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How often patients on insulin therapy measure postprandial glycemia and modify insulin doses accordingly? From an on-line survey in insulin-treated diabetes patients in Spain.
    Lecumberri Pascual E; Tejera Pérez C; Muñoz-Garach A; Javier Ampudia-Blasco F
    Diabetes Res Clin Pract; 2019 Aug; 154():43-51. PubMed ID: 31226281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating the HbA1c assay into estimated average glucose values in children and adolescents with type 1 diabetes mellitus.
    Sayed A; Alyafei F; De Sanctis V; Soliman A; Elgamal M
    Acta Biomed; 2018 May; 89(S5):22-26. PubMed ID: 30049928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS).
    Schaepelynck-Bélicar P; Vague P; Simonin G; Lassmann-Vague V
    Diabetes Metab; 2003 Dec; 29(6):608-12. PubMed ID: 14707890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of postprandial glucose excursions throughout the day in newly diagnosed type 2 diabetes.
    Cichosz SL; Fleischer J; Hoeyem P; Laugesen E; Poulsen PL; Christiansen JS; Ejskjaer N; Hansen TK
    Diabetes Technol Ther; 2013 Jan; 15(1):78-83. PubMed ID: 23176177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new approach for investigating the relative contribution of basal glucose and postprandial glucose to HbA1
    Ma J; He H; Yang X; Chen D; Tan C; Zhong L; Du Q; Wu X; Gao Y; Liu G; Wang C; Ran X
    Nutr Diabetes; 2021 Jun; 11(1):14. PubMed ID: 34088897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of continuous glucose monitoring system to detect unrecognized hypoglycemia in children and adolescents with type 1 diabetes.
    Maia FF; Araújo LR
    Arq Bras Endocrinol Metabol; 2005 Aug; 49(4):569-74. PubMed ID: 16358087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.